Displaying 25 - 36 of 492
Viral Hepatitis

AbbVie: Educate, Motivate, Prioritize, Adapt: Decentralizing Care to Eliminate HCV (Complete Session)

Webcasts
View
Public Health and Advocacy

GSK: Are we on the fastest route? From targets to action on hepatitis B in Europe (Complete Session)

Webcasts
View
Immune-Mediated and Cholestatic Diseases

IPSEN: The Spectrum of Genetic Cholestasis: The Critical Role of Early Diagnosis and Treatment for Adult Patients (Complete Se...

Webcasts
View
Metabolism, Alcohol & Toxicity

Rising to the Need to Improve Diagnosis in the Era of Disease-specific Therapy

Webcasts
View
Metabolism, Alcohol & Toxicity

Integrating MASLD/MASH-Specific Therapy into Guideline-Aligned Real-World Practice

Webcasts
View
Metabolism, Alcohol & Toxicity

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity

Changing the MASH Paradigm With THR-β Agonists and Other Disease-Specific Therapies

Webcasts
View
Metabolism, Alcohol & Toxicity

AKH: A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best Practices for Clinical Integration (Comp...

Webcasts
View
Metabolism, Alcohol & Toxicity

Opella: MASLD: Early screening, Treatment Strategies, and Quality of Life – Insights from New Clinical Evidence (Complete Sess...

Webcasts
View
Metabolism, Alcohol & Toxicity

MASLD – current treatment  strategies  - from metabolic indices to patient reported outcomes

Webcasts
View
Metabolism, Alcohol & Toxicity

Focusing on metabolic risk of MASLD. EXCEL study design and major outcomes

Webcasts
View
Metabolism, Alcohol & Toxicity

Pathophysiological analysis of MASH: targetting clinical manifestations

Webcasts
View
Displaying 25 - 36 of 492